Like a fingerprint, the connections of the human brain render us distinct from one another. In a study published in the February 20th issue of Nature Neuroscience (journal impact factor 16.7), entitled "Delayed stabilization and individualization in connectome development are related to psychiatric disorders", researchers at NORMENT reveal that such a unique, fingerprint-like pattern evolves during development and is sensitive to mental health. First and last authors are Tobias Kaufmann and Lars T. Westlye (photo).
The study has already gained attention, and the results have been discussed in articles published in Science Daily and Medical News Today.
Professor Arne Klungland, section head at the Department of Microbiology, will hold a lecture on the subject of embryonic development during a breakfast meeting held by the The Norwegian Biotechnology Advisory Board (Bioteknologirådet).
Klungland is the leader of several research projects aiming at understanding the first few days during embryonic development, and gain insight into the early development of various diseases.
Time: March 1st 8.15-9.30 AM (breakfast from 8.15, lecture starts 8.30)
Place: Håndverkeren, Galleriet (1st floor)
This is a unique seminar with the Olav Thon Foundation's International Research Awardees for Mathematics and Natural Science and Medicine 2017.
The first talk will be held by International Research Prize winner Jan Hoeijmakers from Erasmus University Rotterdam, who is one of the most significant scientists in molecular genetics of our time.
Further talks will be held by Research Awardee Mahmood Amiry-Moghaddam on Parkinson's disease, and by Research Awardees Henrik Zetterberg and Nenad Bogdanovic on Alzheimer research.
Time and place: March 2nd, 2017 12:00 PM - 03:00 PM, Runde Auditorium R-105 at Domus Medica, Gaustad
Deadline for registration: February 23rd
Sports play an important role in our society. Four Norwegian researchers, two from OUS, have published an article in EMBO reports where they discuss problems occurring in the testing of athletes for doping.
The authors (E. Boye and T. Skotland from OUS (photo), J. Nissen-Meyer from UiO and B. Østerud, UiTø) describe how the World Antidoping Agency (WADA) pretends never to make mistakes and is resistant to any form of discussion with other scientists. This attitude creates false positives and athletes are being sanctioned while innocent, with dramatic consequences for the individual. It is argued that both the technological, ethical and legal procedures should be revised and an independent body should monitor the function of WADA.
Welcome to the next Oslo University Hospital research seminar entitled "Early phase drug development: From idea to concept".
Time: Monday, February 6th, 2017, at 14:30 – 16:00.
Place: Blue Auditorium, Rikshospitalet, Sognsvannsveien 20, Oslo.
The article "Targeting of cancer neoantigens with donor-derived T cell receptor repertoires" by Erlend Strønen et al, published in Science in June 2016, is highlighted by an editorial in the "Clinical Implications of Basic Research" section in the Feb 2nd edition of New England Journal of Medicine.
The editorial is entitled "The Antigenicity of the Tumor Cell — Context Matters".
Every year 16.000 Norwegians are stricken with stroke, and more than 60.000 have previously had one or more strokes. It is therefore important that the foremost Norwegian experts in the field gather in order and be updated on what is new within preventive, acute treatment and rehabilitation from stroke.
David Russell from the Department of Neurology at the Division of Surgery and Clinical Neuroscience at Oslo University Hospital welcomes participants to the 6th national conference on stroke - "den 6. Nasjonale konferanse om Hjerneslag".
The South-Eastern Norway Regional Health Authority (Helse Sør-Øst) aims to profile ongoing excellent research in the region by calling special attention to a "Scientist of the Month".
For the month of January 2017, this honour went to Theis Tønnessen, leader of the "Genetics of autoimmunity and cancer" group at the Department of Medical Genetics at the Division of Diagnostics and Intervention, Oslo University Hospital.
Welcome to the next Oslo University Hospital research seminar entitled "Sepsis: New definitions and future research".
Time: Monday, Thursday, January 26th, 2017, at 13:45 – 15:15.
Place: Red Auditorium, Rikshospitalet, Sognsvannsveien 20, Oslo.
Oslo University Hospital hereby announce research awards in the following two catagories for 2017:
The candidate must be employed by Oslo University Hospital or University of Oslo, and be a member of a research group at Oslo University Hospital/University of Oslo.
Welcome to the next Oslo University Hospital research seminar entitled "Antimicrobial resistance - how bad is the situation in the world of virus, fungus and mycoplasma?".
Time: Monday, January 16th, 2017, at 14:30 – 16:00.
Place: Blue Auditorium, Rikshospitalet, Sognsvannsveien 20
Nadja Katheder and collaborators in the lab of Tor Erik Rusten, the Department of Molecular Cell Biology, and CCB has published an article entitled "Microenvironmental autophagy supports tumor growth", in an advanced online publication 11th of January in the journal Nature (journal impact factor 41.46).
The findings have been subject to news coverage by the Norwegian national broadcasting corporation (NRK).
The prestigious journal "Developmental Cell" has recently published an article in their "Previews" section, entitled "Breaking Down Neighbors to Fuel Tumorigenesis". Here, the authors discuss how the work of Katheder and colleagues "opens new avenues for understanding and manipulating cancers through cell-cell communication."
In the Nature Methods (journal impact factor 25.3) January 2017 issue “Epitranscriptome analysis” is presented as the method of the year. In recent years, it has become clear that RNA molecules, including mRNAs, can be dynamically modified. Thus, this allows for a new strategy for gene regulation with vital biological consequences. Epitranscriptome analysis relates to methods that can profile RNA modifications in a sequence specific manner. In a commentary to this discovery, Klungland and co-workers from Department of Microbiology and Department of Gynecology, OUS, discuss the role of such modifications for the maturation of sperm and egg (meiosis) and pluripotent cells.
The board of the South-Eastern Norway Regional Health Authority (Helse Sør-Øst) has distributed financial resources to new research projects for 2017. Of the in total 568 incoming applications 121 new projects were granted support.
A substantial amount of the resources goes to young researchers. Support is given to a number og doctoral and post doctoral stipendiates, as well as to researcher grants and career grants. The latter category is for young outstanding researchers planning to establish an independent research group.
As part of the collaboration between Oslo Cancer Cluster and Ullern high shool, a total of 40 students visited six different laboratories at the Oslo University Hospital and the National Institute for Public Health last week. A journalist from Framtida.no interviewed the six students who visited the Department for Tumor biologi. Researchers Siri Tveito and Karen-Marie Heintz guided them through immunoflourescence, PCR, gel electrophoresis and other techniques in the lab, and the students were eager to learn about the life of a cancer researcher.
Collaborative efforts by researchers at the Department of Immunology and the Department of Pathology revealed the unexpected potential of tumor-specific Th2 cells for cancer immunotherapy by adoptive cell transfer (ACT) in mice.
The study was published in the December 1st 2016 issue of Cancer Research, the flagship journal of the American Association for Cancer Research. An immunofluorescence microscopy image from the paper was selected to illustrate the journal cover.
Welcome to the next Oslo University Hospital (OUH) research seminar entitled "Exercise and Brain Energy".
Time: Monday, November 21st, 2016, at 14:30 – 16:10
Place: Green Auditorium, Rikshospitalet, Sognsvannsveien 20, Oslo.
Speakers: Linda Hildegard Bergersen, Cecilie Morland, Krister Andresson, Lauritz H. Kennedy, Mahdi Olive Hasan, Johanne Egge Ringholm
Welcome to the next Oslo University Hospital (OUH) research seminar entitled "The World of Immunology".
Time: Thursday November 17th at 10:00-15:00.
Place: Red Auditorium, Rikshospitalet, Sognsvannsveien 20, Oslo.
Speakers: Inger Sandlie, Roland Jonsson, Bart N. Lambrecht, Frode Jahnsen and Erlend Strønen.
The Norwegian Cancer Society has recently distributed in total 179 million NOK to Norwegian cancer researchers. The 34 projects that will receive funding are distributed among seven research institutions in Tromsø, Trondheim, Bergen and Oslo. Twelve research groups are affiliated to Oslo University Hospital. OUH project leaders being supported are Svein Dueland, Jon Amund Kyte, Heidi Lyng, Eirik Malinen, Johanna Olweus, Mouldy Sioud, Erlend Bremertun Smeland, Harald Stenmark, Bjørn Atle Bjørnbeth, Magnar Bjørås, Alexandre Corthay and Jorrit Enserink, and these will altogether receive 77.3 million NOK.
The classical view of tissue macrophages is that they are continuously replaced by blood monocytes, but a paper first-authored by Ibon Eguiluz-Gracia (photo) from Frode Jahnsen's group at the Department of Pathology at OUH and the Centre for Immune Regulation at UiO, recently published in Thorax (journal impact factor 8.3), show that human alveolar macrophages are self-maintained within the lungs for many years. This may be important for development of chronic graft rejection, which is a common complication after lung transplantation and remains the major obstacle to better long-term outcomes.
Furthermore, as pointed out in the accompanying Editorial in Thorax, this study has potential implications for treatment of patients with alveolar proteinosis and COPD.
|Previous news articles|
|Announcement of research funding from the Norwegian Cancer Society Gathering Friday October 28th 10-12 at UiO:|
|Dag Berild awarded the "Akademikerprisen" for his work on antibiotic resistance|
|50 years anniversary Institute for Surgical Research Thursday 13 October 2016 at 10.15 AM|
|Making therapeutic antibodies from scratch|
|Lina Prasmickaite's work presented in popularised form|
|Medical imaging in cardiac research Oslo University Hospital research seminar Monday October 10th|
|Focus on personalized medicine and the MetAction study|
|Histone marks regulate maternal-to-zygotic transition Paper from Dahl/Klungland published in the Sep 22nd issue of Nature|
|Turning the tide of antimicrobial resistance National kick-off, Tuesday September 13th|
|Marina Vietri interviewed for major Italian research web portal|
|OUH researchers publish groundbreaking computer tools for cell biology research in Nature Methods|
|POLE proofreading domain mutations identify a subset of immunogenic colorectal cancers with excellent prognosis|
|Clinical Cancer Research highlights biomarker paper from Lyng’s group|
|The Norwegian Cancer Genomics Consortium participates in international study of gene variants predisposing for cancer development.|
|Annuncement of research funding from South-East Norway regional health authority for 2017 Call for applications 2017|
|H.M. the King's Gold Medal to Marina Vietri|
|Oslo University Hospital has awarded 6 excellent articles for the second half-year of 2015|
|Atle Bjørnerud "Innovator of the Month" South-Eastern Norway Regional Health Authority brings attention to innovation:|
|Tomas Lindahl, Nobel Prize laureate 2015 Symposium at OUS, Rikshospitalet, 17. June 2016 13:00-15:30|
|The 2016 Excellent Research Awards to Pål Aukrust, Therese Seierstad and Espen Melum Oslo University Hospital honouring outstanding scientific work:|
|Strønen and Olweus publish article in Science on the use of donor immunity to target cancer|
|Håvard Danielsen and Erik Fosse receive Lighthouse project grants from the Norwegian Research Council|
|"Intelligent needle tracking using ultrasound imaging for improved minimally invasive interventions" supported by EU OUS scientists partners in project funded by HORIZON 2020 FAST TRACK TO INNOVATION|
|Discovery of biologically active small molecular compounds Oslo University Hospital research seminar Monday May 9th|
|Mapping somatic mutations in breast cancer whole genomes OUS scientists co-author Nature article:|
|Same, but different? Genetic analysis of five immune mediated diseases reveals molecular taxonomy of chronic inflammation|
|Immunotherapy for Cancer Day of Immunology Conference 2016 April 29|
|New guidelines for "Helse Sør-Øst" and "Kreftforeningen" applications Information meeting, Radiumhospitalet, Friday April 22nd|
|Ståle Nygård – Dept. of Core Facilities Institute seminar April 6th|
|Article published in Science Translational Medicine showing that cyclodextrin may reduce atherosclerosis attracts worldwide attention|
|The Fridtjof Nansen Award for Young Scientists for 2016 to Kyrre Eeg Emblem|
|Theodossiou and Berg funded by the Future and Emerging Technology (FET) program|
|King Olav V's cancer research prize for 2016 to Kjetil Taskén|
|Morgendagens medisin The Norwegian Inflammation Network seminar Wednesday March 16th|
|Microbiome Oslo University Hospital research seminar Monday March 14th|
|Liliane Christ identifies mechanism for regulation of daughter cell separation|
|NoPSC study of PSC gut microbiota published in Gut|
|Olav Thon Foundation's International Prize and Research Awardees 2016 Invitation to seminar March 3rd 12:00|
|Stephen H. Friend Norsk Hydro's Fond guest lecture March 10th|
|Ragnhild A. Lothe and Michael Bretthauer substantially supported by FRIPRO|
|Filming live cancer cells Camilla Raiborg's work presented in popularised form on forskning.no:|
|Elderly patients benefit from an early invasive strategy Heart study results recently published in Lancet attract attention:|
|Lorenz et al. published an extensive study investigating the genomic chaos in osteosarcoma|
|Personalized Cancer Care Symposium, Oslo, May 18-20, 2016|
|Åslaug Helland’s research on lung cancer presented by the Norwegian Cancer Society|
|Innovation projects funded by the Norwegian Cancer Society and Research Council|
|Medical imaging in cancer biology and personalized therapy Oslo University Hospital research seminar January 11th|
|Sandvig received INNO INDIGO grant for work with biodegradable nanoparticles|
|Work from Bjørås' group published in "Cell Report"|
|Research funding from South-Eastern Norway Regional Health Authority for 2016|
|AACR Recognizes Dr. Anne-Lise Børresen-Dale With 2015 Distinguished Lectureship in Breast Cancer Research|
|Erik Boye - an internationally renowned scientist retires|
|Oslo University Hospital has awarded 6 excellent articles for the first half-year of 2015|
|New PhD Andreas Hoff publishes testis cancer fusion genes in Cancer Research|
|Asta Juzeniene - Dept. of Radiation Biology Institute Seminar Wednesday 9th of December at 12:00|
|Findings regarding a novel non-genomic tamoxifen cytotoxic action published in ACS Chemical Biology|
|Tor Espen Thorvaldsen with cover story in Molecular Cancer Research|
|Oslo University Hospital researchers receive 92 mill NOK from the Norwegian Cancer Society|
|Ragnar Mørk legacy prize 2015 to Guro E. Lind Ceremony Friday November 20th|
|The first-in-man Phase I clinical trial of the EpCAM-targeting immunotoxin MOC31PE|
|Research on sonoactivatable nanoparticles funded by EuroNanoMed II ERA-NET program|
|Research on nanoparticle radiosensitizers funded by Euronanomed II ERA-NET program|
|PCI research funded by Euronanomed II ERA-NET program|
|Jørgen Wesche – Dept. of Molecular Cell Biology Institute Seminar Wednesday 4th of November at 12:00|
|New gold-standard for miRNA annotations published in Annual Reviews of Genetics|
|The Wonder of Stem Cells in Eye and Oral Regeneration Oslo University Hospital research seminar October 19th|
|Presenting the Young Academy of Norway|
|Prestigious award from the Research Council of Norway to Harald A. Stenmark Møbius 2015:|
|Review article from Sveen and co-workers on alternative splicing published in Oncogene|
|The Anders Jahre Senior Medical Prize to Ludvig Sollid|
|Award winner Erik Fosse presented in Uniforum The UiO Innovation Prize:|
|Two studies of PARP inhibition in malignant lymphocytes reveal differential phenotypical responses, DNA damage induction and repair during the cell cycle|
|Kaisa Haglund receives the Jahre prize for young medical researchers Recognition of outstanding scientific work:|
|Oslo Cancer Cluster Innovation Park officially opened|
|New English version of "The Research Handbook- from idea to publication" is available|
|Chronicle on personalised cancer medicine in Aftenposten|
|Preparing for the upcoming health calls for Horizon 2020 Training course August 25:|
|Novel method reveals new knowledge about G1-phase|
|H.M. The Kings Gold Medal to Sigrid Bratlie Thoresen|
|Llorente and coworkers report promising prostate cancer biomarkers in urinary exosomes|
|Microscopy infrastructure funded by the Norwegian Research Council|
|Innovation prize to Erik Fosse|
|Cover article on personalized cancer medicine and big data in META|
|Paper from OUS/CCB researchers dedicated commentary articles in both Nature and Science|
|What is the cost of a cancer patient's life? OUS research blog June 16th:|
|Annuncement of research funding from South-East Norway regional health authority for 2016 Call for applications 2016|
|The Department of Pathology receives funding for melanoma research through Horizon 2020 project.|
|Findings from the Skarstad group published in PLOS Genetics|
|A cancer cell on the move OUS research blog about endocytosis:|
|William Louch appointed "Scientist of the Month" by "Helse Sør-Øst" for May 2015|
|The long road to success Article about work in the Stenmark group on www.nrk.no:|
|Sealing holes in the nuclear envelope as a mechanism to protect the genome Nature article from Marina Vietri:|
|Non-Homologous functions of the AlkB Homologs – an update of the present knowledge Review article in J Mol Cell Biol:|
|New EU H2020- MARIE Sklodowska-CURIE ACTIONS project coordinated by The Intervention Centre WiBEC (Wireless In-Body Environment Communications) selected for funding by EU|
|Improved methods for the treatment of metabolic diseases affecting children's nervous system OUS research blog:|
|Many OUS teams in the Holmenkollstafetten 2015 Public health improvement:|
|Åsmund Eikenes publishes careers column in Nature|
|Oslo University Hospital honouring excellent research (27.04.2015 11:16)|
|More precise cancer treatment by use of RNA biomarkers OUS research blog from Anja Nilsen: (27.04.2015 11:16)|
|Oslo University Hospital has awarded 6 excellent articles for the second half-year of 2014 (27.04.2015 11:16)|